July 31, 2015 – This week, just in time for World Hepatitis Day on July 28, the American Food and Drug Administration (FDA) approved Daclatasvir (Daklinza)  for use with sofosbuvir to treat hepatitis C virus (HCV) genotype 3 infections. In addition, the …

A very exciting week for patients with hepatitis C viral (HCV) infections of the genotypes 3 and 4 Read more »

July 11, 2015 – According to a global expert,  even with new drug combinations that have cure rates nearing 100%, the fight against the hepatitis C virus is not over. “I believe that an infection present in 130 million to 170 …

Too expensive and too many individuals infected: The high cure rates will not curb hepatitis C Read more »